GLP-3 R
Triple-receptor incretin class agonist studied in metabolic-pathway research.
GLP-3 R designates a synthetic analog in the triple receptor agonist class — the newest generation of incretin research compounds, engineered to engage the GIP, GLP-1, and glucagon receptors simultaneously. Adding glucagon-receptor activity to the dual-incretin profile brings energy-expenditure pathways into play alongside the insulin-secretion and satiety effects of the first two receptors.
The triple-agonist class is the current frontier of metabolic-pathway research, and laboratory demand has followed: receptor-pharmacology groups, adipose-biology labs, and signaling researchers all work with reference material from this family. The published record is young and moving quickly, which makes verified, consistent research material more important, not less.
GLP-3 R is one of the most ordered compounds in the Bench Grade catalog. Every lot is HPLC-verified with its Certificate of Analysis published in the COA library.
Published research
- Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 TrialJastreboff AM, et al. N Engl J Med. 2023.PubMed →
